Our findings revealed that, in vitro, SuPAR: (i) elicits chondrosarcoma cell migration through its uPAR88–92 sequence and (ii) promotes chondrosarcoma cell invasion, the effect being reduced to the basal level by anti-uPAR blocking antibody. Here, PLAUR is linked to chondrosarcoma.